Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	73.64	171.22	168.28	139.38	111.87	131.76
Short-Term Investments	-	-	-	-	-	15
Cash & Short-Term Investments	73.64	171.22	168.28	139.38	111.87	146.76
Cash Growth	-52.05%	1.74%	20.73%	24.59%	-23.77%	78.17%
Accounts Receivable	925.55	554.09	320.85	328.89	427.53	440.54
Other Receivables	56.95	52.48	58.7	0.35	50.33	45.53
Receivables	997.83	625.83	392.07	356.8	509.83	487.47
Inventory	589.28	591.46	465.59	401.77	333.41	281.22
Prepaid Expenses	0.51	3.8	0.26	0.25	-	-
Other Current Assets	85.05	66.69	30.89	89.72	-	-
Total Current Assets	1,746	1,459	1,057	987.92	955.11	915.46
Property, Plant & Equipment	577.61	562.56	453.82	249.24	211.12	150.41
Long-Term Investments	4.93	4.93	4.16	2.6	2.6	2.6
Other Intangible Assets	0	0.01	0.03	0.04	0.06	-
Other Long-Term Assets	-	-	0	-	-	-
Total Assets	2,329	2,026	1,515	1,240	1,169	1,068

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	559.76	435.55	237.1	224.39	142.9	235.93
Accrued Expenses	25.95	19.06	20.18	14.42	-	-
Short-Term Debt	-	22.99	-	56.66	-	-
Current Portion of Long-Term Debt	13.33	40	36.67	-	-	-
Current Income Taxes Payable	117.45	120.14	61.62	29.36	48.13	38.2
Other Current Liabilities	272.64	160.19	113.68	122.19	118.76	84.03
Total Current Liabilities	989.13	797.91	469.25	447.02	309.8	358.16
Long-Term Debt	123.33	123.33	163.33	68.76	-	-
Long-Term Leases	31.62	35.46	37.53	38.85	58.36	-
Long-Term Deferred Tax Liabilities	23.28	23.28	12.49	4.87	6.8	6.58
Other Long-Term Liabilities	-	0	0	-	-	-
Total Liabilities	1,167	979.99	682.6	559.5	374.95	364.74

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	149.34	149.34	149.34	149.34	149.34	149.34
Retained Earnings	870.59	757.84	543.76	383.26	488.51	398.33
Comprehensive Income & Other	141.55	139.32	139.39	147.7	156.09	156.06
Shareholders' Equity	1,161	1,047	832.49	680.31	793.94	703.73
Total Liabilities & Equity	2,329	2,026	1,515	1,240	1,169	1,068

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	168.29	221.78	237.53	164.27	58.36	-
Net Cash (Debt)	-94.65	-50.57	-69.25	-24.88	53.52	146.76
Net Cash Growth	-	-	-	-	-63.53%	79.29%
Net Cash Per Share	-6.34	-3.39	-4.64	-1.67	3.58	9.83
Filing Date Shares Outstanding	14.93	14.93	14.93	14.93	14.93	14.93
Total Common Shares Outstanding	14.93	14.93	14.93	14.93	14.93	14.93
Working Capital	757.17	661.08	587.84	540.89	645.31	557.29
Book Value Per Share	77.77	70.07	55.74	45.55	53.16	47.12
Tangible Book Value	1,161	1,046	832.46	680.26	793.88	703.73
Tangible Book Value Per Share	77.77	70.07	55.74	45.55	53.16	47.12
Land	0.4	0.4	-	0.4	0.4	0.4
Buildings	162.26	151.31	-	53.43	53.42	51.12
Machinery	564.51	545.75	-	291.46	250.9	244.46
Construction In Progress	143.37	128.61	212.7	114.11	81.88	75.24

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error